Related Experiment Video
Updated: Jul 18, 2026
14:45
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
alpha-synuclein and Parkinson's disease: the first roadblock
Christelle En Lin Chua1, Bor Luen Tang
1Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Journal of Cellular and Molecular Medicine
|November 28, 2006
Summary
Mutant alpha-synuclein disrupts neuronal membrane traffic, causing ER stress in Parkinson's disease (PD). Overexpressing Ypt1/Rab1 protein rescues neurodegeneration, offering a potential therapeutic target for PD.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Alpha-synuclein gene mutations are linked to familial Parkinson's disease (PD).
- Alpha-synuclein is a key component of Lewy Bodies, a hallmark of PD pathology.
- The precise function of alpha-synuclein and its role in dopaminergic neuronal death remain unclear.
Purpose of the Study:
- To investigate the role of alpha-synuclein in neuronal membrane traffic.
- To explore the etiological mechanisms underlying alpha-synuclein-induced neurodegeneration.
- To identify potential therapeutic targets for Parkinson's disease.
Main Methods:
- Yeast genetic screen to identify suppressors of alpha-synuclein toxicity.
- Overexpression of Ypt1/Rab1 in yeast, invertebrate, and mammalian models.
- Analysis of endoplasmic reticulum (ER)-to-Golgi transport and ER stress.
- Investigation of alpha-synuclein's interaction with synaptic SNARE proteins.
Main Results:
- Overexpression of alpha-synuclein disrupts ER-to-Golgi transport, leading to ER stress.
- Overexpression of Ypt1/Rab1 suppresses alpha-synuclein toxicity in yeast.
- Ypt1/Rab1 overexpression rescues neuron loss in models of alpha-synuclein-induced neurodegeneration.
- Alpha-synuclein may function as a chaperone for synaptic SNARE proteins.
Conclusions:
- Alpha-synuclein interferes with neuronal membrane traffic, contributing to PD pathogenesis.
- Ypt1/Rab1 represents a promising therapeutic target for mitigating alpha-synuclein toxicity in PD.
- Understanding alpha-synuclein's interaction with membrane traffic pathways is crucial for PD research.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...